Literature DB >> 8486006

Sleep apnea syndrome and end-stage renal disease. Cure after renal transplantation.

B Langevin1, D Fouque, P Léger, D Robert.   

Abstract

We report two patients undergoing maintenance hemodialysis who presented with sleep apnea syndrome (SAS). The first patient is a 36-year-old man with a terminal Berger's glomerulopathy and associated obstructive sleep apnea syndrome (OSAS) (apnea-hypopnea index [AHI] = 80). He was receiving home hemodialysis and was treated by nasal continuous positive airway pressure (CPAP). After successful renal transplantation, his symptoms completely disappeared, and control polysomnography greatly improved (AHI = 9). The second patient had hypokalemic nephropathy with severe, uncontrolled hypertension and hypertensive myocardiopathy. He was receiving home dialysis and showed a central sleep apnea syndrome with an AHI of 51. He also was successfully treated by nasal CPAP. After renal transplantation, his sleep improved, insomnia disappeared, and polysomnography showed great improvement (AHI = 5). We discuss the role of periodic breathing related to end-stage renal disease associated metabolic abnormalities, as a pathogenetic factor of these SASs. Respiratory correction of chronic metabolic acidosis, "uremic toxins," "middle molecules," and hemodialysis are all evoked as etiologic factors and their own roles are discussed.

Entities:  

Mesh:

Year:  1993        PMID: 8486006     DOI: 10.1378/chest.103.5.1330

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Sleep physiology, abnormal States, and therapeutic interventions.

Authors:  Alvah T Wickboldt; Alex F Bowen; Aaron J Kaye; Adam M Kaye; Franklin Rivera Bueno; Alan D Kaye
Journal:  Ochsner J       Date:  2012

2.  Sleep-disordered breathing in children with chronic kidney disease.

Authors:  Reshma Amin; Neha Sharma; Khamisa Al-Mokali; Priya Sayal; Suhail Al-Saleh; Indra Narang; Elizabeth Harvey
Journal:  Pediatr Nephrol       Date:  2015-07-09       Impact factor: 3.714

Review 3.  Supine fluid redistribution: should we consider this as an important risk factor for obstructive sleep apnea?

Authors:  Aibek E Mirrakhimov
Journal:  Sleep Breath       Date:  2012-08-08       Impact factor: 2.816

Review 4.  Obstructive Sleep Apnea and Kidney Disease: A Potential Bidirectional Relationship?

Authors:  Bisher Abuyassin; Kumar Sharma; Najib T Ayas; Ismail Laher
Journal:  J Clin Sleep Med       Date:  2015-08-15       Impact factor: 4.062

Review 5.  Anaesthetic management of patients with sleep apnoea syndrome.

Authors:  N N Boushra
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

6.  Sleep disturbances in pediatric dialysis patients.

Authors:  Ira D Davis; Joshua Baron; Mary Ann O'riordan; Carol L Rosen
Journal:  Pediatr Nephrol       Date:  2004-11-24       Impact factor: 3.714

7.  Sleep apnea is associated with cardiovascular risk factors among kidney transplant patients.

Authors:  Miklos Zsolt Molnar; Alpar Sandor Lazar; Anett Lindner; Katalin Fornadi; Maria Eszter Czira; Andrea Dunai; Rezso Zoller; Andras Szentkiralyi; Laszlo Rosivall; Colin Michael Shapiro; Marta Novak; Istvan Mucsi
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-19       Impact factor: 8.237

Review 8.  Sleep disorders and quality of life in renal transplant recipients.

Authors:  Miklos Zsolt Molnar; Marta Novak; Istvan Mucsi
Journal:  Int Urol Nephrol       Date:  2009-01-31       Impact factor: 2.370

9.  Resolution of sleep-disordered breathing in a dialysis-dependent child post-renal transplantation.

Authors:  Emma Ball; Tonya Kara; David McNamara; Elizabeth A Edwards
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

10.  Improvement in sleep apnea during nocturnal peritoneal dialysis is associated with reduced airway congestion and better uremic clearance.

Authors:  Sydney C W Tang; Bing Lam; Andrew S H Lai; Clara B Y Pang; Wai Kuen Tso; Pek Lan Khong; Mary S M Ip; Kar Neng Lai
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-31       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.